echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Prostate: Investigation of predictors of recurrence in holmium laser enucleation of prostate

    Prostate: Investigation of predictors of recurrence in holmium laser enucleation of prostate

    • Last Update: 2021-12-04
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Benign prostatic hyperplasia (BPH) is one of the most common causes of lower urinary tract symptoms (LUTS) in men
    .
    Surgical treatment is usually the treatment of choice for patients with moderate/severe drug-refractory LUTS


    .


    Transurethral resection of the prostate (TURP) and open prostatectomy (OP) are the gold standards for the treatment of small/medium and large prostates.


    Holmium laser enucleation of the prostate (HoLEP) is one of the most studied surgical techniques for benign prostatic hyperplasia (BPH), and its efficacy in relieving symptoms has been widely described
    .
    However, there is little evidence on predictors of symptom recurrence


    .


    Evaluated the long-term outcome, symptom recurrence rate, and predictors of patients receiving HoLEP.


    The researchers analyzed data on patients with benign prostatic hyperplasia who received consecutive HoLEP treatment at two tertiary referral centers from 2012 to 2015
    .
    At 12 months, 24 months, and 60 months of follow-up, the functional results were evaluated by urine flow rate parameters and the International Prostate Symptom Score (IPSS) questionnaire


    .


    A total of 567 patients’ data are available for analysis
    .
    Before surgery, the median prostate volume of all patients was 80cc, the median PFR was 8ml/s, and the median PVR was 100cc


    .


    Multivariate logistic regression analysis of predictors of symptomatic patients 60 months after HolEP surgery

    Multivariate logistic regression analysis of predictors of symptomatic patients 60 months after HolEP surgery

    In summary, no matter which technique is selected, HoLEP can alleviate symptoms lastingly
    .
    For patients with important symptoms or high PVR before surgery, the risk of recurrence of symptoms should be carefully considered


    .



    Original source:

    Matteo Droghetti Angelo Porreca, Lorenzo Bianchi et al.


    Long-term outcomes of Holmium laser enucleation of prostate and predictive model for symptom recurrence .


    Long-term outcomes of Holmium laser enucleation of prostate and predictive model for symptom recurrence

     

    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.